Atlas Trials

Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing

Clinical trial NCT04356781 · COMPLETED

Trial details

NCT number
NCT04356781
Sponsor
Walton Centre NHS Foundation Trust
Status
COMPLETED
Study type
OBSERVATIONAL
Multifocal Motor Neuropathy (MMN)Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Start date
2020-09-28
Primary completion
2024-12-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.